— Know what they know.
Not Investment Advice

PLYX NASDAQ

Polaryx Therapeutics, Inc. Common Stock
1W: -1.6% 1M: -7.8% 3M: -5.5% YTD: -94.6%
$1.88
+0.06 (+3.30%)
 
Weekly Expected Move ±5.0%
$2 $2 $2 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 24 · $93.7M mcap · 23M float · 0.322% daily turnover · Short 58% of daily vol
Credit Risk of going bust: not rated Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Not rated: insufficient price history. Altman Z'' -12.99.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Balance Sheet Trends

Total Assets
$5M +8.4% ▲
Total Liabilities
$855K +195.8% ▲
Shareholders Equity
$5M -3.1% ▼
Cash & Investments
$5M +11.3% ▲
Total Debt
$0 +0.0% ▲
Net Debt
-$5M -11.3% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2025
— Assets —
Cash$5M
Short-Term Investments$0
Cash & ST Investments$5M
Net Receivables$0
Inventory$0
Other Current Assets$27K
Total Current Assets$5M
Property, Plant & Equip.$0
Goodwill & Intangibles$0
Long-Term Investments$0
Other Non-Current Assets$0
Total Non-Current Assets$250K
Total Assets$5M
— Liabilities —
Accounts Payable$470K
Short-Term Debt$0
Deferred Revenue$0
Other Current Liabilities$114K
Total Current Liabilities$605K
Long-Term Debt$0
Other Non-Current Liab.$0
Total Non-Current Liabilities$250K
Total Liabilities$855K
— Equity —
Common Stock$5K
Retained Earnings-$100M
Accumulated OCI$0
Total Stockholders Equity$5M
Total Liabilities & Equity$5M
— Key Metrics —
Total Debt$0
Net Debt-$5M
Total Investments$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms